Literature DB >> 430189

Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent.

D M Wieland, D P Swanson, L E Brown, W H Beierwaltes.   

Abstract

Tissue distributions of four antiadrenergic agents labeled with iodine-125 have been determined in dogs. [125I] ortho-iodobenzldimethyl-2-hydroxyethyl ammonium and [125I] ortho-iodobenzyldimethylethyl ammonium show highly selective uptake in the adrenal medulla. Studies of molecular structure-distribution indicate that both the nature of the cationic head and the ring position of the iodine atom greatly influence adrenal specificity. Distinct images of dogs' adrenal medulla have been obtained 4 days after i.v. injection of 1.5 mCi of [131I] ortho-iodobenzyldimethyl-2-hydroxyethyl ammonium.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 430189

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  20 in total

1.  Aberrant I-123 MIBG uptake in a gastrointestinal stromal tumour.

Authors:  David van Dellen; Otilia Maria Mitu-Pretorian; Titus Augustine
Journal:  Updates Surg       Date:  2012-01-10

Review 2.  Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.

Authors:  B Shapiro
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 3.  Targeted radiotherapy for neuroblastoma.

Authors:  S Meller
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

Review 4.  Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.

Authors:  Arnold F Jacobson; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

5.  Adrenal radiography: problems and pitfalls in adrenal localization.

Authors:  G W Geelhoed; E M Druy
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

Review 6.  Norepinephrine Transporter as a Target for Imaging and Therapy.

Authors:  Neeta Pandit-Taskar; Shakeel Modak
Journal:  J Nucl Med       Date:  2017-09       Impact factor: 10.057

7.  Efficacy of using a standard activity of (131)I-MIBG therapy in patients with disseminated neuroendocrine tumours.

Authors:  Shaunak Navalkissoor; Dona M Alhashimi; Ann-Marie Quigley; Martyn E Caplin; John R Buscombe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

Review 8.  Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities.

Authors:  A P van Gils; A R van Erkel; T H Falke; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1994-03

Review 9.  Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.

Authors:  Camilo Jimenez; Eric Rohren; Mouhammed Amir Habra; Thereasa Rich; Paola Jimenez; Montserrat Ayala-Ramirez; Eric Baudin
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

10.  Noradrenergic innervation of the pineal gland--histochemical basis of scintigraphic imaging?

Authors:  H Schröder
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.